Literature DB >> 27128409

Meldonium (Mildronate): A Performance-Enhancing Drug?

H Karl Greenblatt1, David J Greenblatt1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27128409     DOI： 10.1002/cpdd.264

Source DB:  PubMed          Journal:  Clin Pharmacol Drug Dev        ISSN： 2160-763X


× No keyword cloud information.
  5 in total

Review 1.  Opinion paper: scientific, philosophical and legal consideration of doping in sports.

Authors:  Massimo Negro; Natale Marzullo; Francesca Caso; Luca Calanni; Giuseppe D'Antona
Journal:  Eur J Appl Physiol       Date:  2018-02-09       Impact factor: 3.078

2.  Advances in the Understanding and Treatment of Mitochondrial Fatty Acid Oxidation Disorders.

Authors:  Eric S Goetzman
Journal:  Curr Genet Med Rep       Date:  2017-07-25

Review 3.  Review of WADA Prohibited Substances: Limited Evidence for Performance-Enhancing Effects.

Authors:  Jules A A C Heuberger; Adam F Cohen
Journal:  Sports Med       Date:  2019-04       Impact factor: 11.136

4.  19F NMR studies on γ-butyrobetaine hydroxylase provide mechanistic insights and suggest a dual inhibition mode.

Authors:  Robert K Leśniak; Anna M Rydzik; Jos J A G Kamps; Amjad Kahn; Timothy D W Claridge; Christopher J Schofield
Journal:  Chem Commun (Camb)       Date:  2019-12-05       Impact factor: 6.222

5.  Human carnitine biosynthesis proceeds via (2S,3S)-3-hydroxy-Nε-trimethyllysine.

Authors:  Robert K Leśniak; Suzana Markolovic; Kaspars Tars; Christopher J Schofield
Journal:  Chem Commun (Camb)       Date:  2016-12-22       Impact factor: 6.222
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.